The average one-year price target for Aardvark Therapeutics (NasdaqGS:AARD) has been revised to $18.77 / share. This is a decrease of 43.62% from the prior estimate of $33.29 dated February 21, 2026.

When Aardvark Therapeutics announced earlier this month that it was pausing a phase 3 trial of its lead metabolic candidate, ...

Aardvark Therapeutics, Inc. (NASDAQ:AARD) is one of the penny stocks with potential to rise 1000 percent. Aardvark ...

Voluntary pause of the Phase 3 HERO and OLE trials evaluating ARD-101 for the treatment of hyperphagia in individuals with Prader-Willi Syndrome, ...

Aardvark Therapeutics’ obesity asset is based on its lead molecule, which in February was linked to reversible heart safety ...

Add Yahoo as a preferred source to see more of our stories on Google. The aardvark calf, born to mom Karanga and dad Winsol, represents an incredible milestone for the Zoo. Prior to the calf’s birth, ...

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Aardvark Therapeutics (AARD) has drawn investor attention after voluntarily pausing its ...

Add Yahoo as a preferred source to see more of our stories on Google. An aardvark in the Tussen-die-Riviere Nature Reserve in South Africa. Nigel Denis / Alamy via bioGraphic Animals of all kinds mix ...

Over the past several months, the social search service Aardvark has gained a lot of fans. But what’s somewhat peculiar is that most of those users interact with the site via email or IM, rather than ...

Yesterday brought the news that Google has officially purchased Aardvark, a small San-Francisco-based social search startup that happens to have been created by former Google employees. The timing, ...

Google has announced the acquisition of Aardvark for a reported $50 million, and with it a new way to leverage social networks to find fast, relevant answers to questions. My PCWorld peer Jeff ...